HeraMED Limited (1I4) — Strategic Asset Allocation Index
HeraMED Limited (1I4) has a Strategic Asset Allocation Index of 4.2% as of December 2025. Strategic assets (PP&E of €- plus long-term investments of €39.32K) total €39.32K, measured against net assets of €931.03K. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See HeraMED Limited balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
HeraMED Limited Strategic Asset Allocation Index (2018–2025)
This chart shows how HeraMED Limited's Strategic Asset Allocation Index has evolved across 4 annual periods from 2018 to 2025. As of December 2025, the index stands at 4.2%, representing strategic assets of €39.32K against net assets of €931.03K EUR. For live market cap and overall valuation, see HeraMED Limited market cap and net worth.
Annual Strategic Asset Allocation Index for HeraMED Limited (2018–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for HeraMED Limited from 2018 to 2025, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See net assets of HeraMED Limited for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 4.2% | €39.32K | €- | €39.32K | €931.03K | ▲ +3.4 pp |
| 2020 | 0.8% | €22.00K | €22.00K | €- | €2.59 Million | ▼ -1.8 pp |
| 2019 | 2.6% | €89.44K | €89.44K | €- | €3.41 Million | ▲ +2.4 pp |
| 2018 | 0.3% | €15.53K | €15.53K | €- | €6.15 Million | — |